(RTTNews) - ANI Pharmaceuticals, Inc. (ANIP), Wednesday announced the launch of Nitazoxanide Tablets, 500 mg that are the generic version of the reference listed drug Alinia.

Oral- Cryptosporidiosis, Giardiasis- Adult: 500 mg every 12 hour for 3 days. Child: 1-3 year: 100 mg every 12 hour; 4-11 year: 200 mg every 12 hour; ≥12 years: 500 mg every 12 hour. All doses to ...

ANI Pharmaceuticals is introducing nitazoxanide tablets, 500 mg, which is the generic of Alinia. The medication is used to treat diarrhea caused by certain parasites.

--ANI Pharmaceuticals, Inc. today announced the launch of Nitazoxanide Tablets, 500 mg. U.S. annual sales for Nitazoxanide Tablets total approximately $36.1 million, based on December 2024 moving ...

Group II (treatment-experienced) included: Arm 3 (intervention arm) with 58 patients who received Levofloxacin 500 mg once daily, Vonoprazan 20 mg twice daily, Nitazoxanide 500 mg twice daily, and ...

A sustained virologic response (undetectable HCV RNA) twelve weeks after the end of treatment (SVR12) occurred in 44% of patients treated with nitazoxanide (500 mg twice daily) plus standard ...

An ongoing clinical trial is expected to provide data on the activity of nitazoxanide at a dose of 500 mg BD, either alone or along with hydroxychloroquine, against SARS-CoV-2.

ANI Pharmaceuticals (ANIP) announced the launch of Nitazoxanide Tablets, 500 mg. ANI’s Nitazoxanide Tablets are the generic version of the reference listed drug, or RLD, Alinia. U.S. annual ...

PRINCETON, N.J., March 19, 2025 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced the launch of Nitazoxanide Tablets, 500 mg. ANI’s Nitazoxanide ...

PRINCETON, N.J., March 19, 2025 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced the launch of Nitazoxanide Tablets, 500 mg. ANI’s Nitazoxanide ...